998 related articles for article (PubMed ID: 9297994)
41. Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.
Kocemba J; Kawecka-Jaszcz K; Gryglewska B; Grodzicki T
J Hum Hypertens; 1998 Sep; 12(9):621-6. PubMed ID: 9783491
[TBL] [Abstract][Full Text] [Related]
42. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
43. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
44. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
[TBL] [Abstract][Full Text] [Related]
45. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A;
J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957
[TBL] [Abstract][Full Text] [Related]
46. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
47. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
48. Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial.
Wang JG; Liu G; Wang X; Zhang S; Sun M; Pan X; Jian M; Gong L; Thijs L; Staessen J; Fagard R; Liu L
J Hum Hypertens; 1996 Nov; 10(11):735-42. PubMed ID: 9004103
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
[TBL] [Abstract][Full Text] [Related]
50. Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Kurata C
J Am Coll Cardiol; 1998 Aug; 32(2):438-43. PubMed ID: 9708473
[TBL] [Abstract][Full Text] [Related]
51. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
52. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Results of a six-month double-blind trial.
Sassano P; Chatellier G; Billaud E; Alhenc-Gelas F; Corvol P; Ménard J
Am J Med; 1987 Aug; 83(2):227-35. PubMed ID: 3039842
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension.
Wang JG; Staessen JA; Fagard RH; Birkenhäger WH; Gong L; Liu L
Hypertension; 2001 Apr; 37(4):1069-74. PubMed ID: 11304505
[TBL] [Abstract][Full Text] [Related]
54. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ; Palmer CR; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
Lancet; 2000 Jul; 356(9227):366-72. PubMed ID: 10972368
[TBL] [Abstract][Full Text] [Related]
55. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
Silagy CA; McNeil JJ; McGrath BP
Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
[TBL] [Abstract][Full Text] [Related]
56. SYST-EUR multicentre trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
Slovick DI; Amery A; Birkenhager W; Bulpitt CJ; Cox J; de Leeuw P; de Cort P; Fagard R; Fletcher A; Forette F
J Hum Hypertens; 1993 Apr; 7(2):201-3. PubMed ID: 8510096
[No Abstract] [Full Text] [Related]
57. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
[TBL] [Abstract][Full Text] [Related]
58. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
[TBL] [Abstract][Full Text] [Related]
59. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.
Hansson L; Lindholm LH; Ekbom T; Dahlöf B; Lanke J; Scherstén B; Wester PO; Hedner T; de Faire U
Lancet; 1999 Nov; 354(9192):1751-6. PubMed ID: 10577635
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension.
Fagard RH; Staessen JA; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Leonetti G; Sarti C; Tuomilehto J; Webster J; Yodfat Y;
Hypertension; 2004 Oct; 44(4):459-64. PubMed ID: 15326091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
